公开(公告)号：US11931170B2

公开(公告)日：2024-03-19

申请号：US16706474

申请日：2019-12-06

申请人： Pulmonx Corporation

发明人： Ajit Nair ,  Son Gia ,  Roger Farhnoltz ,  Nikolai Aljuri

IPC分类号： A61B5/00 ,  A61B5/08 ,  A61B5/085 ,  A61B5/097 ,  A61B17/12 ,  A61F2/04 ,  A61M16/04 ,  A61M16/08 ,  A61M25/00 ,  A61M25/06

CPC分类号： A61B5/4836 ,  A61B5/08 ,  A61B5/085 ,  A61B5/097 ,  A61B5/6853 ,  A61B17/12104 ,  A61M16/04 ,  A61M16/0406 ,  A61M16/0866 ,  A61M25/0075 ,  A61M25/0662 ,  A61F2002/043 ,  A61M2025/0004 ,  A61M2025/0681

摘要： Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.

公开(公告)号：US10517529B2

公开(公告)日：2019-12-31

申请号：US15250917

申请日：2016-08-30

申请人： Pulmonx Corporation

发明人： Ajit Nair ,  Son Gia ,  Roger Farhnoltz ,  Nikolai Aljuri

IPC分类号： A61B5/00 ,  A61M16/04 ,  A61M25/00 ,  A61M25/06 ,  A61B5/085 ,  A61B5/097 ,  A61B17/12 ,  A61B5/08 ,  A61F2/04

摘要： Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.

公开(公告)号：US20170128004A1

公开(公告)日：2017-05-11

申请号：US15250917

申请日：2016-08-30

申请人： Pulmonx Corporation

发明人： Ajit Nair ,  Son Gia ,  Roger Farhnoltz ,  Nikolai Aljuri

IPC分类号： A61B5/00 ,  A61B17/12 ,  A61B5/08

CPC分类号： A61B5/4836 ,  A61B5/08 ,  A61B5/085 ,  A61B5/097 ,  A61B5/6853 ,  A61B17/12104 ,  A61F2002/043 ,  A61M16/04 ,  A61M16/0406 ,  A61M16/0866 ,  A61M25/0075 ,  A61M25/0662 ,  A61M2025/0004 ,  A61M2025/0681

摘要： Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.

公开(公告)号：US09439583B2

公开(公告)日：2016-09-13

申请号：US13689344

申请日：2012-11-29

申请人： Pulmonx Corporation

发明人： Ajit Nair ,  Son Gia ,  Roger Farhnoltz ,  Nikolai Aljuri

IPC分类号： A61M16/04 ,  A61M25/01 ,  A61B5/08 ,  A61B5/097 ,  A61B5/085 ,  A61M25/00 ,  A61M25/06 ,  A61B5/00 ,  A61B17/12 ,  A61F2/04

CPC分类号： A61B5/4836 ,  A61B5/08 ,  A61B5/085 ,  A61B5/097 ,  A61B5/6853 ,  A61B17/12104 ,  A61F2002/043 ,  A61M16/04 ,  A61M16/0406 ,  A61M16/0866 ,  A61M25/0075 ,  A61M25/0662 ,  A61M2025/0004 ,  A61M2025/0681

摘要： Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.